Exact Mass: 358.0138022

Exact Mass Matches: 358.0138022

Found 19 metabolites which its exact mass value is equals to given mass value 358.0138022, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

MPTA

4-(N-Maleimido)phenyltrimethylammonium iodide

C13H15N2O2. I (358.017824)

2-Iodomelatonin

N-[2-(2-Iodo-5-methoxy-1H-indol-3-yl)ethyl]ethanimidate

C13H15IN2O2 (358.01782399999996)

D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones

1-(6-Chloro-9H-purin-9-yl)-1-deoxy-2,3-O-isopropylidene-beta-D-ribofuranuronoyl chloride

C13H12Cl2N4O4 (358.0235572)

tert-Butyl 3-iodo-5-methyl-1H-pyrrolo[2,3-b]pyridine-1-carboxylate

C13H15IN2O2 (358.01782399999996)

1-[(4-chlorophenyl)methyl]-3-(3,4-dichlorophenyl)-1-methoxyurea

C15H13Cl3N2O2 (358.0042568)

4-[2,5-Bis(2,2,2-trifluoroethoxy)phenyl]-1,2,3-thiadiazole

C12H8F6N2O2S (358.02106599999996)

Mifobate

C11H17ClO7P2 (358.0138022)

C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C154291 - Peroxisome Proliferator-Activated Receptor Agonist Mifobate (SR-202) is a potent and specific PPARγ antagonist. Mifobate (SR-202) selectively inhibits Thiazolidinedione (TZD)-induced PPARγ transcriptional activity (IC50=140 μM). Mifobate (SR-202) does not affect basal or ligand-stimulated transcriptional activity of PPARα, PPARβ, or the farnesoid X receptor (FXR). Mifobate (SR-202) shows antiobesity and antidiabetic effects[1].